In this study, we advanced the understanding of aging and AD pathology through the mechanistic modelling of how gene activity modulates relevant biological factors (e.g., tau, Aβ, CBF, neuronal activity) to drive the cognitive alterations typically observed in the associated populations. Here, MAPT is linked to Alzheimer disease.